Genpharmasec Ltd

AI
Genpharmasec Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Genpharmasec Ltd

₹ 1.07 7.00%
16 Oct - close price
genpharmasec.com BSE: 531592
About

Incorporated in 1992, Generic Pharmasec
Ltd deals in pharmaceutical activities /services and trades in equity shares[1]

Key Points

Business Overview:[1]
GPL started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and then shifted its business activities to buying, selling and distribution of pharmaceutical, medicinal and medicated preparations and also decided to deal in securities market. Currently, company is dealing in medical and diagnostics devices

Website BSE
  • Market Cap ₹ 59.2 Cr.
  • Current Price ₹ 1.07
  • High / Low ₹ 1.85 / 0.75
  • Stock P/E 10.8
  • Book Value ₹ 1.29
  • Dividend Yield 0.00 %
  • ROCE 9.59 %
  • ROE 7.90 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.83 times its book value
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 34.0% CAGR over last 5 years
  • Debtor days have improved from 112 to 77.9 days.
  • Company's working capital requirements have reduced from 132 days to 51.9 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 32.1%
  • Company has a low return on equity of 4.76% over last 3 years.
  • Earnings include an other income of Rs.5.02 Cr.
  • Promoter holding has decreased over last 3 years: -27.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
5.96 7.86 6.38 10.20 5.30 5.77 8.34 13.56 12.11 31.56 36.01 51.66 44.78
5.94 7.89 6.37 10.04 5.07 5.52 7.40 14.56 11.10 31.05 36.69 50.07 43.43
Operating Profit 0.02 -0.03 0.01 0.16 0.23 0.25 0.94 -1.00 1.01 0.51 -0.68 1.59 1.35
OPM % 0.34% -0.38% 0.16% 1.57% 4.34% 4.33% 11.27% -7.37% 8.34% 1.62% -1.89% 3.08% 3.01%
0.11 0.15 0.14 0.31 0.58 0.86 0.93 1.06 0.82 1.00 1.43 1.62 0.97
Interest 0.06 0.07 0.12 0.14 0.07 0.04 0.11 0.06 0.08 0.08 0.19 0.25 0.13
Depreciation 0.01 0.00 0.00 0.00 0.00 0.04 0.05 0.04 0.04 0.04 0.07 0.09 0.10
Profit before tax 0.06 0.05 0.03 0.33 0.74 1.03 1.71 -0.04 1.71 1.39 0.49 2.87 2.09
Tax % 66.67% 80.00% -100.00% 115.15% 18.92% 2.91% 35.67% 500.00% 8.77% 41.01% -55.10% 19.16% 25.36%
0.03 0.01 0.06 -0.05 0.59 1.00 1.11 -0.23 1.56 0.82 0.76 2.32 1.57
EPS in Rs 0.00 0.00 0.00 -0.00 0.01 0.02 0.02 -0.00 0.03 0.01 0.01 0.04 0.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
0 0 0 0 0 16 21 27 26 30 33 131 164
0 0 1 0 0 16 20 28 25 30 32 129 161
Operating Profit -0 -0 -0 -0 -0 1 1 -1 0 0 1 2 3
OPM % -1,900% -12% -38% -21% 3.9% 6% -1.9% 1.0% 0.5% 2.3% 1.8% 1.7%
0 0 0 0 0 1 0 0 0 1 3 5 5
Interest 0 0 0 0 0 0 0 0 0 0 0 1 1
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 0 0 1 2 -0 0 0 4 6 7
Tax % 0% 0% 0% 33% 21% 17% 17% -52% -300% 91% 26% 15%
0 0 0 0 0 1 1 -0 1 0 3 5 5
EPS in Rs 0.00 0.01 0.03 0.07 0.01 0.02 0.02 -0.00 0.02 0.00 0.05 0.10 0.09
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 44%
3 Years: 73%
TTM: 312%
Compounded Profit Growth
10 Years: 75%
5 Years: 34%
3 Years: 69%
TTM: 59%
Stock Price CAGR
10 Years: 20%
5 Years: -25%
3 Years: -24%
1 Year: -40%
Return on Equity
10 Years: %
5 Years: 4%
3 Years: 5%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 0.33 0.33 22 22 28 28 28 55 55 55
Reserves -8 -7 -1 -1 -0 -3 -7 -12 -12 9 11 16
1 1 1 1 0 0 0 0 3 3 3 5
0 0 0 0 0 6 7 6 1 3 9 34
Total Liabilities 0 0 1 0 22 25 28 22 20 70 79 110
0 0 0 0 0 0 0 0 0 0 0 1
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 8 6 8 2 1 20 21 22
0 0 1 0 14 19 20 19 19 51 58 87
Total Assets 0 0 1 0 22 25 28 22 20 70 79 110

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 0 -0 0 -6 1 -2 -2 -3 -2 1 2
0 0 0 0 -10 -4 -1 0 0 -29 -3 -2
0 -0 0 -0 22 0 4 0 3 48 -0 -0
Net Cash Flow 0 0 0 0 5 -3 1 -2 0 17 -2 0
Free Cash Flow 0 0 -0 0 -6 1 -2 -2 -3 -2 1 2
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -8% -91% 83% -433% 7,925% 223% -162% 400% -1,277% -1,487% 132% 114%

Ratios

Standalone / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 0 388 0 38 156 129 86 82 109 148 78
Inventory Days 0 0 83 146 136 151 133 87 36
Days Payable 133 135 85 21 36 98 87
Cash Conversion Cycle 0 388 0 38 106 139 137 211 207 137 27
Working Capital Days 0 46 -137 941 117 144 150 199 205 139 52
ROCE % 57% -36% 10% 43% 2% 6% 8% -2% 2% 2% 6% 10%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Permanent Employees
employees

Log in to view insights

Please log in to see hidden values.

Login
Diagnostic Pharma Equipment Segment Revenue (Standalone)
Rs. in Lakhs
Trading in Securities Segment Revenue (Standalone)
Rs. in Lakhs
i-STAT Analyzers Imported (units)
units
Simulators Imported (units)
units
i-STAT Cartridges Imported (units)
units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
59.96% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 32.06%
40.04% 70.02% 70.02% 70.02% 70.02% 70.02% 70.02% 70.03% 70.01% 70.02% 70.02% 67.95%
No. of Shareholders 89,4381,08,1371,08,2201,05,8381,09,2061,09,0801,07,6021,05,8041,04,0211,02,2521,01,13499,856

Documents

Announcements

Annual reports